Credit Suisse’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2.11M Buy
142,154
+1,541
+1% +$21.1K ﹤0.01% 1821
2023
Q4
$1.29M Buy
140,613
+18,535
+15% +$128K ﹤0.01% 2172
2023
Q3
$680K Sell
122,078
-872
-0.7% -$6.1K ﹤0.01% 2515
2023
Q2
$991K Buy
122,950
+87,210
+244% +$643K ﹤0.01% 2385
2023
Q1
$234K Buy
35,740
+8
+0% +$33 ﹤0.01% 3075
2022
Q4
$87.9K Buy
35,732
+1,144
+3% +$3.58K ﹤0.01% 3352
2022
Q3
$173K Buy
34,588
+612
+2% +$3.57K ﹤0.01% 3295
2022
Q2
$145K Sell
33,976
-2,154
-6% -$13.7K ﹤0.01% 3435
2022
Q1
$360K Buy
36,130
+10,462
+41% +$77.8K ﹤0.01% 3148
2021
Q4
$202K Buy
+25,668
New +$322K ﹤0.01% 4271

Other funds holding OSCR

Credit Suisse's OSCR Position: Q1 2024 in Review

Credit Suisse increased its Oscar Health (OSCR) stake by 1.1% in Q1 2024, buying an estimated $21.1K and bringing the position to 142,154 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1821.

Credit Suisse first reported a position in OSCR in Q4 2021 and has held it in 10 quarters since. 220 funds tracked by Wall St. Rank hold OSCR as of Q1 2024.

  • Credit Suisse held 142,154 shares of Oscar Health worth $2.11M as of Q1 2024.
  • Credit Suisse bought 1,541 Oscar Health shares in Q1 2024, an estimated $21.1K.
  • Oscar Health made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1821 holding.
  • Credit Suisse first reported a position in Oscar Health in Q4 2021 and has held it in 10 quarters since.
  • 220 funds tracked by Wall St. Rank held Oscar Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.